Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma Academic Article uri icon


MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Membrane Glycoproteins
  • Proteoglycans
  • Receptor, Epidermal Growth Factor


  • The authors demonstrated that expression of either of the nonsmall cell lung carcinoma subtype classifiers syndecan-1 and EGFR was associated with a 30% reduction in the risk of death, with this reduction being independent of histology and other confounders. The results of the current study suggest that loss of expression of these histologic classifiers is associated with biologic aggressiveness in lung tumors and with poor outcome for patients with such tumors. If their significance can be validated prospectively, these biomarkers may be used to guide therapeutic planning for patients with nonsmall cell lung carcinoma.

publication date

  • October 2004



  • Academic Article



  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.20542

PubMed ID

  • 15378500

Additional Document Info

start page

  • 1632

end page

  • 8


  • 101


  • 7